Renal & Urology News6h
In CKD, Both Calcified and Low-Attenuation Plaques Predict MACE Risk
Risk for all-cause mortality and MACEs are affected by calcified and low-attenuation plaque burdens in patients with chronic kidney disease.
Toxin in blood of kidney disease patients could contribute to stroke risk, study suggests
Scientists have revealed that a toxin found in the blood of patients with chronic kidney disease (CKD) damages the body's ...
U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...